Literature DB >> 18789949

The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

Valeriy G Ostapchenko1, Natallia Makarava, Regina Savtchenko, Ilia V Baskakov.   

Abstract

Individual variations in structure and morphology of amyloid fibrils produced from a single polypeptide are likely to underlie the molecular origin of prion strains and control the efficiency of the species barrier in the transmission of prions. Previously, we observed that the shape of amyloid fibrils produced from full-length prion protein (PrP 23-231) varied substantially for different batches of purified recombinant PrP. Variations in fibril morphology were also observed for different fractions that corresponded to the highly pure PrP peak collected at the last step of purification. A series of biochemical experiments revealed that the variation in fibril morphology was attributable to the presence of miniscule amounts of N-terminally truncated PrPs, where a PrP encompassing residue 31-231 was the most abundant of the truncated polypeptides. Subsequent experiments showed that the presence of small amounts of recombinant PrP 31-231 (0.1-1%) in mixtures with full-length PrP 23-231 had a dramatic impact on fibril morphology and conformation. Furthermore, the deletion of the short polybasic N-terminal region 23-30 was found to reduce the folding efficiency to the native alpha-helical forms and the conformational stability of alpha-PrP. These findings are very surprising considering that residues 23-30 are very distant from the C-terminal globular folded domain in alpha-PrP and from the prion folding domain in the fibrillar form. However, our studies suggest that the N-terminal polybasic region 23-30 is essential for effective folding of PrP to its native cellular conformation. This work also suggests that this region could regulate diversity of prion strains or subtypes despite its remote location from the prion folding domain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789949      PMCID: PMC2597535          DOI: 10.1016/j.jmb.2008.08.073

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  59 in total

1.  Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Pier Giorgio Righetti; Sergio Ferrari; Liliana Terrin; Alessia Farinazzo; Franco Cardone; Maurizio Pocchiari; Nicola Rizzuto; Salvatore Monaco
Journal:  Electrophoresis       Date:  2002-01       Impact factor: 3.535

Review 2.  Shattuck lecture--neurodegenerative diseases and prions.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

3.  The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein.

Authors:  Claire Sunyach; Angela Jen; Juelin Deng; Kathleen T Fitzgerald; Yveline Frobert; Jacques Grassi; Mary W McCaffrey; Roger Morris
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

4.  Identification of the heparan sulfate binding sites in the cellular prion protein.

Authors:  Richard G Warner; Christoph Hundt; Stefan Weiss; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

5.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein.

Authors:  B Vincent; E Paitel; P Saftig; Y Frobert; D Hartmann; B De Strooper; J Grassi; E Lopez-Perez; F Checler
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

6.  Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein.

Authors:  Max Nunziante; Sabine Gilch; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

7.  Dual mechanisms for shedding of the cellular prion protein.

Authors:  Edward T Parkin; Nicole T Watt; Anthony J Turner; Nigel M Hooper
Journal:  J Biol Chem       Date:  2004-01-07       Impact factor: 5.157

Review 8.  Copper binding in the prion protein.

Authors:  Glenn L Millhauser
Journal:  Acc Chem Res       Date:  2004-02       Impact factor: 22.384

9.  Cell-surface prion protein interacts with glycosaminoglycans.

Authors:  Tao Pan; Boon-Seng Wong; Tong Liu; Ruliang Li; Robert B Petersen; Man-Sun Sy
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

10.  Anterograde and retrograde intracellular trafficking of fluorescent cellular prion protein.

Authors:  Naomi S Hachiya; Kota Watanabe; Makiko Yamada; Yuji Sakasegawa; Kiyotoshi Kaneko
Journal:  Biochem Biophys Res Commun       Date:  2004-03-19       Impact factor: 3.575

View more
  18 in total

1.  The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance.

Authors:  Robert Tycko; Regina Savtchenko; Valeriy G Ostapchenko; Natallia Makarava; Ilia V Baskakov
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines.

Authors:  Silvia Lisa; Massimiliano Meli; Gema Cabello; Ruth Gabizon; Giorgio Colombo; María Gasset
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

3.  Conformational switching within individual amyloid fibrils.

Authors:  Natallia Makarava; Valeriy G Ostapchenko; Regina Savtchenko; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

4.  Posttranslational modifications define course of prion strain adaptation and disease phenotype.

Authors:  Natallia Makarava; Jennifer Chen-Yu Chang; Kara Molesworth; Ilia V Baskakov
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

5.  Two amyloid States of the prion protein display significantly different folding patterns.

Authors:  Valeriy G Ostapchenko; Michael R Sawaya; Natallia Makarava; Regina Savtchenko; K Peter R Nilsson; David Eisenberg; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2010-05-27       Impact factor: 5.469

6.  Purification and fibrillation of full-length recombinant PrP.

Authors:  Natallia Makarava; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2012

7.  Highly neurotoxic monomeric α-helical prion protein.

Authors:  Minghai Zhou; Gregory Ottenberg; Gian Franco Sferrazza; Corinne Ida Lasmézas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-07       Impact factor: 11.205

8.  Prion nucleation site unmasked by transient interaction with phospholipid cofactor.

Authors:  Ashley A Zurawel; Daniel J Walsh; Sean M Fortier; Tamutenda Chidawanyika; Suvrajit Sengupta; Kurt Zilm; Surachai Supattapone
Journal:  Biochemistry       Date:  2014-01-02       Impact factor: 3.162

9.  Purification and Fibrillation of Full-Length Recombinant PrP.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2017

10.  Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1.

Authors:  Michele L Kadnar; Gulnara Articov; Irina L Derkatch
Journal:  PLoS Genet       Date:  2010-01-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.